Frontiers in Pharmacology (Aug 2024)
Editorial: Diabetes and cardiovascular disease: new therapeutic interventions
- Maria Consiglia Trotta,
- Michele D’Amico,
- Ludwig T. Weckbach,
- Ludwig T. Weckbach,
- Ludwig T. Weckbach,
- Ludwig T. Weckbach,
- Anca Hermenean,
- Anca Hermenean,
- Bartolo Ferraro,
- Bartolo Ferraro
Affiliations
- Maria Consiglia Trotta
- Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy
- Michele D’Amico
- Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy
- Ludwig T. Weckbach
- German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
- Ludwig T. Weckbach
- Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig- Maximilian-University Munich, Munich, Germany
- Ludwig T. Weckbach
- Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-University Munich, Munich, Germany
- Ludwig T. Weckbach
- Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-University Munich, University Hospital, Munich, Germany
- Anca Hermenean
- Faculty of Medicine, Vasile Goldis Western University of Arad, Arad, Romania
- Anca Hermenean
- “Aurel Ardelean” Institute of Life Sciences, Vasile Goldis Western University of Arad, Arad, Romania
- Bartolo Ferraro
- Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig- Maximilian-University Munich, Munich, Germany
- Bartolo Ferraro
- Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-University Munich, Munich, Germany
- DOI
- https://doi.org/10.3389/fphar.2024.1472636
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords